By Scott Meacham As i2E has been closing our latest round of new investments over the last few weeks, I am reminded of how in the startup world and the venture industry, investment events attract attention. I don’t usually write about investment events. The celebratory milestones have already occurred over the weeks, months, and yearsRead more
By Stephen Prescott, M.D. When Novartis announced earlier this month that the U.S. Food and Drug Administration had approved the company’s new drug to treat sickle cell anemia, the press release didn’t mention Oklahoma. But it should have. That drug, known as Adakveo, is as Oklahoman as redbuds and scissor-tailed flycatchers. Indeed, but for workRead more
By Scott Meacham Lupus is chronic autoimmune condition with devastating effects. The disease is difficult to diagnose. Its course is unpredictable. There is no cure and few FDA-approved medications. Patients who have lupus live with its impact for the rest of their lives. At times, the disease flares up and gets worse; in remission, symptomsRead more
By Scott Meacham Copyright © 2019, The Oklahoman Of the more than 120 types of brain and central nervous system tumors, Glioblastoma (also called GBM) is the most aggressive — a deadly brain cancer with no cure. Glioblastomas often appear with no warning or prior symptoms. These Type IV tumors tend to produce their ownRead more
By Adam Kemp Staff writer akemp@oklahoman.com Emma Turner thought about taking a summer off. Thoughts of laying by the pool, road trips and just enjoying being lazy for three months all sounded like fine ways to spend her first semester home from college. But instead, Turner, along with more than a dozen other OklahomaRead more
By Jim Stafford Copyright © 2019, The Oklahoman Five patients are waiting to see their doctor, each displaying different symptoms. One has a bright rash on her face. Another is suffering from arthritis. Still another has kidney failure, while the fourth patient suffers from heart problems and the fifth is fatigued all the time. TurnsRead more
Copyright © 2018, The Oklahoman Scientists at Oklahoma Medical Research Foundation will expand their studies of Sjögren’s syndrome after securing a $2.7 million grant from the National Institutes of Health. The foundation’s Darise Farris, Ph.D., will serve as the principal investigator on the five-year grant. The project will focus on comparing certain immune cells inRead more
‘Show Us the Money’ Editor’s note: This article was written by Manu Nair, vice president of Technology Ventures with the Oklahoma Medical Research Foundation Friends and collaborators in industry often ask me about the availability of structured capital to fund biotech spin-offs in Oklahoma. It’s an astute question—but the answer might surprise you. Historically, OklahomaRead more
‘Show Us the Money’ Editor’s note: This article was written by Manu Nair, vice president of Technology Ventures with the Oklahoma Medical Research Foundation Friends and collaborators in industry often ask me about the availability of structured capital to fund biotech spin-offs in Oklahoma. It’s an astute question—but the answer might surprise you. Historically, OklahomaRead more
‘Show Us the Money’ Editor’s note: This article was written by Manu Nair, vice president of Technology Ventures with the Oklahoma Medical Research Foundation Friends and collaborators in industry often ask me about the availability of structured capital to fund biotech spin-offs in Oklahoma. It’s an astute question—but the answer might surprise you. Historically, OklahomaRead more
